← Browse by Condition
Medical Condition
refractory transformed chronic lymphocytic leukemia
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 1
NCT05873712 Phase 2
Recruiting
Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome
Enrollment
24 pts
Location
United States
Sponsor
Aseel Alsouqi
NCT07166419 Phase 1
Recruiting
Anti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, and Chronic Lymphocytic Leukemia
Enrollment
24 pts
Location
United States
Sponsor
Ohio State University Comprehe...